Artemis Global Life Sciences (Delisted) share price history

BSE: 540616

Last traded ₹49.45 on 23 Oct 2019

Delisted on 27 May 2020.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

Oct 2019
- 22 Oct · Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
  In Accordance with Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing herewith copy of Certificate dated .... (opens in a new tab)
- 17 Oct · Suspension of Trading
  Members of the Exchange are hereby informed that the trading in Equity Shares of Artemis Global Life Sciences Limited shall be suspended w.e.f. October 24, 2019 (i.e. closing hours of trading on October 23, 2019) on account of Scheme of Amalgamation of Artemis Global Life Sciences Limited with Artemis Medicare Services Limited
- 16 Oct · Shareholding for the Period Ended September 30, 2019
  Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....
- 15 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 15 Oct · Updates
  Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ( Company ), Artemis Health Sciences Limited ( AHSL ), Athena Eduspark Limited ( AEL ) and Artemis Medicare Services Limited ( AMSL ) under Section 230 to 232 of Companies Act 2013 ( Composite Scheme ) (opens in a new tab)
- 14 Oct · Corporate action
  Company has fixed Record Date as October 25, 2019 for the purpose of determining the eligibility of the shareholders of the Company to whom equity shares of AMSL will be issued in terms of the Composite Scheme. (opens in a new tab)

Results

Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results

Quarter to Jun 2019, against the quarter beforeFiled 16 Aug

Revenue: ₹136 Crdown 3.17%
Net profit: ₹4.27 Crdown 22.07%
Net margin: 3.1%

Revenue by year

Peak revenue ₹547 Cr, year to Mar 2019

Net profit by year, a loss in red

₹ crore	Jun 2018Filed 7 Aug	Sep 2018Filed 17 Nov	Dec 2018Filed 5 Feb	Mar 2019Filed 13 May	Jun 2019Filed 16 Aug
Revenue	126	141	139	140	136
Net profit	4	6	5	5	4
Net margin	2.9%	4.5%	3.5%	3.9%	3.1%

Consolidated. The 5 quarters from Jun 2018, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.

Business segments

In the year to Mar 2019 the company reports one business segment, Healthcare, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2019, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	−38.3%	−21.9%	−21.0%	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.

Artemis Global Life Sciences share price by year

Each calendar year to 2019.

Year	Close at year end	Change	Highest close	Lowest close
2019	49.45	−22.9%	69.95	44.10
2018	64.15	−45.7%	127.75	62.40
2017	118.15	–	147.10	115.05

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2017 is from its first session, 20 Jul 2017. The 2019 close is its last trade, on 23 Oct 2019.

Recent sessions

The last 10 trading days to 23 Oct 2019, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
23 Oct 2019	54.95	54.95	47.20	49.45	50.38	5,489
22 Oct 2019	57.95	60.95	50.30	51.10	53.49	29,861
18 Oct 2019	50.00	55.55	50.00	50.90	52.96	29,802
17 Oct 2019	49.95	50.10	48.10	49.15	48.84	968
16 Oct 2019	50.50	51.90	49.00	49.20	50.81	5,447
15 Oct 2019	52.00	52.00	48.15	50.20	50.00	2,432
14 Oct 2019	49.00	49.50	48.05	48.10	48.57	6,097
11 Oct 2019	49.40	51.85	48.90	49.10	50.06	13,718
10 Oct 2019	49.00	51.50	48.15	48.90	49.92	7,011
9 Oct 2019	49.20	50.95	49.15	50.05	49.97	2,471

Prices in ₹ per share as traded, not adjusted.

Company details

Legal name: Artemis Global Life Sciences Limited
BSE code: 540616
ISIN: INE517U01013
Listed: Jul 2017
Face value: ₹2
Former symbols: AGLSL
Website: www.aglsl.in (opens in a new tab)
CIN: L85191DL2011PLC216530; Corporate identity number, the registrar of companies' code for it